China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2012 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on February 28, 2012

Feb 21, 2012, 07:03 ET from China Cord Blood Corporation

HONG KONG, Feb. 21, 2012 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("the Company") today announced its plan to release financial results for the third quarter and first nine months of fiscal year 2012 on Monday, February 27, 2012, after market close in the US.

The Company will host a conference call at 8:00 a.m. ET on Tuesday, February 28, 2012 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session. Interested parties may access the audio webcast through the Company's IR website at A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above. Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or +852-2475-0994 for Hong Kong callers, access code: 44773603.

Please dial in ten minutes prior to the conference call to ensure proper connection, and be prepared to provide your name and company to the operator.

Supplemental financial information referenced in the conference call and the third quarter fiscal 2012 earnings press release will be available at, in the section titled Investor Center/Press Release, after 4:00 p.m. ET on Monday, February 27, 2012.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses.  Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at

For more information, please contact:

China Cord Blood Corporation Ms. Joeling Law Tel: (+852) 3605-8180 Email:

ICR, Inc. Mr. Rob Koepp Tel: +86-10-6583-7516

Ms. Wen Lei Zheng: Tel:  +86-10-6583-7510 U.S. Tel: +1-646-405-5185

SOURCE China Cord Blood Corporation